Previous investigations have identified Wnt pathway activation across meningiomas with SSVs targeting TRAF7, KLF4, PIK3CA, POLR2A, the Hedgehog pathway, and even NF2 and SMARCB125. This evidence concerns the gene NF2 and meningioma.